Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biosimilars
Pharma
Teva CEO celebrates progress in 'Pivot to Growth' plan
While Teva still has a "long way to go," the company is executing well on its Pivot to Growth strategy, CEO Richard Francis told Fierce.
Fraiser Kansteiner
May 8, 2024 3:02pm
Amid promising launch of Humira biosim, Sandoz sees 6% growth
May 7, 2024 11:17am
Boehringer charts layoffs due to poor Humira biosim sales
Apr 5, 2024 11:19am
Eisai, Carvykti, Ozempic biosimilar—Fierce Pharma Asia
Apr 5, 2024 8:25am
Teva inks cancer biosimilar marketing pact with mAbxience
Apr 4, 2024 10:33am
Biocon sells insulin and other brands to Eris for $150M
Mar 14, 2024 11:34am